Search
Generic filters
Search in excerpt

An ETF for every investor.

CASH

Horizons High Interest Savings ETF

Price
$50.19
$0.01
0.02%
NAV
$50.1700
$0.0067
0.01%

Benchmark

Fixed Income

Fact Sheet
Learn more about CASH

QQCC

Horizons NASDAQ-100 Covered Call ETF

Price
$9.78
$0.10
1.03%
NAV
$9.7097
$0.0803
0.83%

Active

Covered Call

Fact Sheet
Learn more about QQCC

HRAA

Horizons ReSolve Adaptive Asset Allocation ETF

Price
$10.96
$0.03
0.27%
NAV
$10.9882
$0.0724
0.66%

Active

Corporate Class – Alternative

Fact Sheet
Learn more about HRAA
Explore All Products
Search
Generic filters
Search in excerpt
Back to All Products

HVAX

Horizons Global Vaccines and Infectious Diseases Index ETF

Get Exposure to the Companies Leading Vaccine Development

Horizons Global Vaccines and Infectious Diseases Index ETF (HVAX), allows investors to gain exposure to the potentially long-term theme of vaccine development and disease prevention.

Key Features

• Provides globally diversified exposure to leading companies that provide research, medicines and vaccines against infectious diseases
• Massive public and private investment during COVID-19 pandemic driving exciting innovation in vaccine and pharmaceutical development
• COVID-19 has likely created a long-term focus on global disease prevention, a potentially long-term trend
• Substantial revenue opportunities from further vaccine and infectious disease development beyond COVID-19

Investment Objective

HVAX seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the development and production of vaccines, therapeutics and diagnostics. Currently, HVAX seeks to replicate, directly or indirectly, the performance of the Solactive Global Vaccines and Infectious Diseases Index, net of expenses. HVAX seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.

Fund Details

Ticker
HVAX
Inception Date
October 26, 2021
Net Assets ?
$2,279,728
As at  January 26, 2023
Consolidated Prior Day Volume ?
1,000
For  January 26, 2023
Average Daily Trading Volume Over a 12 Month Period ?
314
As at  January 26, 2023
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOCGVAXN
Management Fee
0.60%
Management Expense Ratio ?
0.71%
As at June 30, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
54930023BO8TOEE8TG37
Most Recent Distributions Per Unit
0.10324
Estimated Annualized Yield ?
0.64 %
12-Month Trailing Yield ?
0.63 %
Distribution Frequency
Annual
Record Date
December 30, 2022
NAV / Unit
$17.1021
Price
$16.91
Premium Discount
$-0.19
Premium Discount Percentage
-1.14%
Outstanding Shares
133,301

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Global Vaccines and Infectious Diseases Index ETF -5.93 9.97 -7.08 -32.13 -32.13 -- -- -- -29.74
Solactive Global Vaccines and Infectious Diseases Index -5.82 11.07 -7.48 -32.74 -32.74 -- -- -- -30.64

**Fund performance since inception on October 26, 2021, as at December 31, 2022

Calendar Year Performance (%) *

2015 2016 2017 2018 2019 2020 2021 2022

Horizons Global Vaccines and Infectious Diseases Index ETF

-- -- -- -- -- -- -- -32.13
Solactive Global Vaccines and Infectious Diseases Index -- -- -- -- -- -- -- -32.74

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2022 12/29/2022 12/30/2022 01/12/2023 0.10324 Annual

Sector Allocation

As at December 30, 2022
Health Care 100.00%

Geographic Exposure

As at December 30, 2022
United States 65.29%
France 10.82%
Germany 9.17%
China 7.60%
Britain 4.59%
Denmark 1.29%
South Korea 1.23%

Top 10 Holdings

As at January 26, 2023
Security Name Weight
Moderna Inc 6.88%
Vir Biotechnology Inc 6.02%
BioNTech SE - ADR 5.65%
Sanofi SA - ADR 5.61%
CureVac NV 5.09%
Valneva SE 4.91%
Pfizer Inc 4.80%
Adaptive Biotechnologies Corp 4.77%
3SBio Inc 4.65%
Merck & Co Inc 4.64%

Holdings are subject to change. Download full prior business day: Holdings

At a Glance

Get Exposure to the Companies Leading Vaccine Development

Horizons Global Vaccines and Infectious Diseases Index ETF (HVAX), allows investors to gain exposure to the potentially long-term theme of vaccine development and disease prevention.

Key Features

• Provides globally diversified exposure to leading companies that provide research, medicines and vaccines against infectious diseases
• Massive public and private investment during COVID-19 pandemic driving exciting innovation in vaccine and pharmaceutical development
• COVID-19 has likely created a long-term focus on global disease prevention, a potentially long-term trend
• Substantial revenue opportunities from further vaccine and infectious disease development beyond COVID-19

Product Facts

Investment Objective

HVAX seeks to replicate, to the extent possible and net of expenses, the performance of an index that is designed to provide exposure to the performance of global, publicly listed companies generally engaged in the development and production of vaccines, therapeutics and diagnostics. Currently, HVAX seeks to replicate, directly or indirectly, the performance of the Solactive Global Vaccines and Infectious Diseases Index, net of expenses. HVAX seeks to hedge any U.S. dollar portfolio exposure back to the Canadian dollar at all times.

Fund Details

Ticker
HVAX
Inception Date
October 26, 2021
Net Assets ?
$2,279,728
As at January 26, 2023
Consolidated Prior Day Volume ?
1,000
For January 26, 2023
Average Daily Trading Volume Over a 12 Month Period ?
314
As at January 26, 2023
Exchange
Toronto Stock Exchange
Investment Manager
Horizons ETFs Management (Canada) Inc.
Eligibility
All Registered and Non-Registered Investment Accounts
Bloomberg Index Ticker
SOCGVAXN
Management Fee
0.60%
Management Expense Ratio ?
0.71%
 As at June 30, 2022
Currency
CAD
Currency Hedging
Seeks to hedge the U.S. dollar value of its portfolio to the Canadian dollar at all times
LEI ?
54930023BO8TOEE8TG37
Most Recent Distributions Per Unit
0.10324
Estimated Annualized Yield ?
0.64%
12-Month Trailing Yield ?
0.63%
Distribution Frequency
Annual
Record Date
December 30, 2022
NAV / Unit
$17.1021
Price
$16.91
Premium Discount
$-0.19
Premium Discount Percentage
-1.14%
Outstanding Shares
133,301

The NAV chart above only shows the historical daily net asset value per unit (NAV) of the ETF, and identifies the various distributions made by the ETF, if any. The distributions are not treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses. The chart is not a performance chart and is not indicative of future NAV values which will vary.

The Growth of 10K chart above is based on the historical daily net asset value per unit (NAV) of the ETF, and represents the value of an initial investment into the ETF of $10,000 since its inception, on a total return basis. Distributions, if any, are treated as reinvested, and it does not take into account sales, redemption, distribution or optional charges or income taxes payable by any security holder. The NAV values do contemplate management fees and other fund expenses where paid by the fund. The chart is not a performance chart and is not indicative of future value which will vary.

Performance & Distributions

Annualized Performance (%) *

1mo 3mo 6mo YTD 1 yr 3 yr 5 yr 10 yr SIR**
Horizons Global Vaccines and Infectious Diseases Index ETF -5.93 9.97 -7.08 -32.13 -32.13 -- -- -- -29.74
Solactive Global Vaccines and Infectious Diseases Index -5.82 11.07 -7.48 -32.74 -32.74 -- -- -- -30.64

**Fund performance since inception on October 26, 2021, as at December 31, 2022

Calendar Year Performance (%)

2015 2016 2017 2018 2019 2020 2021 2022
Horizons Global Vaccines and Infectious Diseases Index ETF -- -- -- -- -- -- -- -32.13
Solactive Global Vaccines and Infectious Diseases Index -- -- -- -- -- -- -- -32.74

Distributions

Year Ex-Dividend Date Record Date Payment Date Payment Amount Reinvested Non-Cash Distributions Distribution Period
2022 12/29/2022 12/30/2022 01/12/2023 0.10324 Annual
Holdings

Sector Allocation

As at December 30, 2022
Health Care 100.00%

Geographic Exposure

As at  December 30, 2022
United States 65.29%
France 10.82%
Germany 9.17%
China 7.60%
Britain 4.59%
Denmark 1.29%
South Korea 1.23%

Top 10 Holdings

As at January 26, 2023
Security Name Weight
Moderna Inc 6.88%
Vir Biotechnology Inc 6.02%
BioNTech SE - ADR 5.65%
Sanofi SA - ADR 5.61%
CureVac NV 5.09%
Valneva SE 4.91%
Pfizer Inc 4.80%
Adaptive Biotechnologies Corp 4.77%
3SBio Inc 4.65%
Merck & Co Inc 4.64%

Holdings are subject to change. Download full prior business day: Holdings

Related Posts

At Horizons ETFs, we believe in education as empowerment. We endeavor to equip Canadian investors with the knowledge and tools they need to navigate the investing world. From the ETF basics to more complex topics like how our suite of inverse and leveraged funds work, our comprehensive learning library aims to be accessible for all investors, from beginners to experienced traders!